These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 484566)

  • 21. Drug usage evaluation of aminoglycoside-induced nephrotoxicity in a community hospital.
    Wade WE; McCall CY
    Hosp Formul; 1990 Oct; 25(10):1092-4, 1096. PubMed ID: 10107391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An evaluation of a pharmacy based aminoglycoside monitoring service.
    Tierney MG; Braden LA
    Can J Hosp Pharm; 1984; 37(4):135-6, 143. PubMed ID: 10269317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the cost of an aminoglycoside level?
    Rich DS; Roby C; Kelley A
    Am J Hosp Pharm; 1987 Jun; 44(6):1312, 1314. PubMed ID: 3618606
    [No Abstract]   [Full Text] [Related]  

  • 24. Hospital pharmacy-based service for patient-controlled analgesia.
    Wong EY; Thompson MV; Dudgeon MA; Swenson JP
    Am J Hosp Pharm; 1990 Feb; 47(2):364-9. PubMed ID: 2309727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishing a clinical pharmacokinetic service for gentamicin in a community hospital.
    Wallace SM; Gesy K; Gorecki DK
    Can J Hosp Pharm; 1984; 37(1):10-4. PubMed ID: 10265730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacist-driven aminoglycoside quality improvement program.
    Greenwood BC; Szumita PM; Lowry CM
    J Chemother; 2009 Feb; 21(1):42-5. PubMed ID: 19297271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of clinical pharmacist consultations on the use of drug blood level tests.
    Elenbaas RM; Payne VW; Bauman JL
    Am J Hosp Pharm; 1980 Jan; 37(1):61-4. PubMed ID: 7361775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computer-based program for identifying medication orders requiring dosage modification based on renal function.
    Goldberg DE; Baardsgaard G; Johnson MT; Jolowsky CM; Shepherd M; Peterson CD
    Am J Hosp Pharm; 1991 Sep; 48(9):1965-9. PubMed ID: 1928142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacy-based antimicrobial-monitoring service.
    Berman JR; Zaran FK; Rybak MJ
    Am J Hosp Pharm; 1992 Jul; 49(7):1701-6. PubMed ID: 1621727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computer-assisted antimicrobial-use monitoring.
    Inaraja MT; Paloma JM; Giráldez J; Idoate AJ; Hualde S
    Am J Hosp Pharm; 1986 Mar; 43(3):664-70. PubMed ID: 3754692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions.
    Hayman JN; Sbravati EC
    Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A utilization and cost-benefit analysis of an aminoglycoside kinetics monitoring service.
    Pinilla J; Shafran S; Conly J
    Clin Invest Med; 1992 Feb; 15(1):8-17. PubMed ID: 1572110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Financial impact of an aminoglycoside substitution program.
    Andrews JD; Stad K
    Can J Hosp Pharm; 1987 Feb; 40(1):23-6. PubMed ID: 10281256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aminoglycoside monitoring: use of a pharmacokinetic service versus physician recommendations.
    Smith M; Murphy JE; Job ML; Ward ES
    Hosp Formul; 1987 Jan; 22(1):92-9, 102. PubMed ID: 10280287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aminoglycoside utilization study.
    Haslett TM; Reynolds JR
    Hosp Pharm; 1988 Oct; 23(10):872, 874-5, 878-80. PubMed ID: 10290108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of patients treated by an aminoglycoside pharmacokinetic dosing service.
    Sveska KJ; Roffe BD; Solomon DK; Hoffmann RP
    Am J Hosp Pharm; 1985 Nov; 42(11):2472-8. PubMed ID: 4073064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality assurance in a clinical pharmacy program.
    Shaw MA; Russell WL; Bradham DD
    QRB Qual Rev Bull; 1984 Mar; 10(3):87-9. PubMed ID: 6427727
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacist monitoring of drug therapy in patients with abnormal serum creatinine levels.
    Golightly LK; O'Fallon CL; Moran WD; Sorocki AH
    Hosp Pharm; 1993 Aug; 28(8):725-7, 730-2. PubMed ID: 10127574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacist interventions to improve prescribing of vancomycin and tobramycin.
    Fletcher CV; Giese RM; Rodman JH
    Am J Hosp Pharm; 1986 Sep; 43(9):2198-201. PubMed ID: 3766572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of pharmacokinetic indices with therapeutic outcome in patients receiving aminoglycosides.
    Deziel-Evans LM; Murphy JE; Job ML
    Clin Pharm; 1986 Apr; 5(4):319-24. PubMed ID: 3709080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.